EDAP TMS SA (EDAP)

Currency in USD
4.200
-0.060(-1.41%)
Closed·
4.2000.000(0.00%)
·
Trading near 52-week High
EDAP is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.1604.430
52 wk Range
1.2104.430
Key Statistics
Prev. Close
4.2
Open
4.26
Day's Range
4.16-4.43
52 wk Range
1.21-4.43
Volume
85.86K
Average Volume (3m)
63.77K
1-Year Change
72.1311%
Book Value / Share
0.73
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EDAP Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
6.833
Upside
+62.70%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

EDAP TMS SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

EDAP TMS SA Company Profile

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also offers Focal One, a HIFU robotic system to treat patients diagnosed with prostate cancer, as well as disposables, and leasing and treatment related services; and maintenance services. The ESWL segment manufactures and markets lithotripter for the treatment of urinary tract stones; and provides disposables, replacement parts, and services for lithotripters. This segment also sells spare parts and disposables, such as electrodes. The Distribution segment markets, distributes, and services lasers, micro-ultrasound systems, and other medical products from third parties, as well as leases devices; sells disposables and spare parts; and offers maintenance services. It markets and sells its products through its direct marketing and sales channels, as well as through third-party distributors and agents. The company serves academic, public, and private hospitals as well as urology clinics. EDAP TMS S.A. was incorporated in 1979 and is based in Vaulx-en-Velin, France.

EDAP TMS SA Earnings Call Summary for Q3/2025

  • EDAP TMS reported Q3 2025 net loss of €0.13 per share, beating analyst expectations of -$0.2108, with revenue reaching €13.9 million, up 6% year-over-year, driven by 49% growth in HIFU sales.
  • The company maintained its 2025 guidance, projecting total revenue of $58-62 million with HIFU business growth of 26-34%, while non-core businesses may decline by 25-30%.
  • Gross margin improved to 43% from 39.4% in the previous year, reflecting effective cost management despite InvestingPro data showing negative EBITDA of $21.73 million over the last twelve months.
  • EDAP's stock rose 2.46% following the earnings announcement, with CEO Ryan Rhodes highlighting 'meaningful progress in reimbursement coverage' as a key strategic achievement.
  • Management identified potential US tariff policies as a risk factor being monitored, while maintaining focus on accelerating Focal One adoption and expanding market access.
Last Updated: 2025-11-06, 09:20 a/m
Read Full Transcript

Compare EDAP to Peers and Sector

Metrics to compare
EDAP
Peers
Sector
Relationship
P/E Ratio
−6.7x−3.4x−0.6x
PEG Ratio
−0.560.080.00
Price/Book
5.7x2.5x2.6x
Price / LTM Sales
2.1x2.9x3.4x
Upside (Analyst Target)
−4.8%28.6%44.9%
Fair Value Upside
Unlock−3.3%6.3%Unlock

Analyst Ratings

1 Buy
2 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 6.833
(+62.70% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Hold2.50-40.48%1.50MaintainJan 20, 2026
Jefferies
Hold2.00-52.38%1.80MaintainNov 06, 2025
H.C. Wainwright
Buy14.00+233.33%19.00MaintainMay 16, 2025
Piper Sandler
Hold---DowngradeMay 15, 2025
Jefferies
Hold2.00-52.38%8.00DowngradeApr 04, 2025

Earnings

Latest Release
Nov 06, 2025
EPS / Forecast
-0.13 / -0.2108
Revenue / Forecast
13.88M / 11.58M
EPS Revisions
Last 90 days

EDAP Income Statement

People Also Watch

3.68
NAMM
-34.87%
18.490
ISSC
-2.94%
37.74
PARR
+3.48%
34.600
TERN
+1.17%
4.470
CLYM
-6.49%

FAQ

What Is the EDAP (EDAP) Stock Price Today?

The EDAP stock price today is 4.200

What Stock Exchange Does EDAP Trade On?

EDAP is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for EDAP?

The stock symbol for EDAP is "EDAP."

What Is the EDAP Market Cap?

As of today, EDAP market cap is 157.05M.

What Is EDAP's Earnings Per Share (TTM)?

The EDAP EPS (TTM) is -0.52.

When Is the Next EDAP Earnings Date?

EDAP will release its next earnings report on Apr 01, 2026.

From a Technical Analysis Perspective, Is EDAP a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has EDAP Stock Split?

EDAP has split 0 times.

How Many Employees Does EDAP Have?

EDAP has 310 employees.

What is the current trading status of EDAP (EDAP)?

As of Feb 02, 2026, EDAP (EDAP) is trading at a price of 4.200, with a previous close of 4.200. The stock has fluctuated within a day range of 4.160 to 4.430, while its 52-week range spans from 1.210 to 4.430.

What Is EDAP (EDAP) Price Target According to Analysts?

The average 12-month price target for EDAP is USD6.833, with a high estimate of USD14 and a low estimate of USD2.5. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +62.70% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.